Preliminary scientific tests indicate conolidine may perhaps inhibit unique ion channels, minimizing neuronal excitability and limiting pain signals. This system is especially appropriate in neuropathic discomfort, in which irregular signaling causes persistent soreness. Furthermore, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to soreness percepti... https://josephk816jsm9.wikicorrespondent.com/user